FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Martignetti

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Loss of Heterozygosity

Physiology

Living Beings

Mouse

Anatomy

Tumor Cell Line

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Rebecca A Mosig; John A Martignetti
Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.
Rémi Favier; Nathalie Hezard; Pierre Bedossa; Analisa Difeo; Monique Fabre; John A Martignetti
A new feature of the MYH9-related syndrome: chronic transaminase elevation.
Olga Camacho-Vanegas; Irene Miranda-Lorenzo; Berrin Ozturk; Jacob Till; Sandra Catalina Camacho; John A Martignetti
Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Martignetti (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rebecca A Mosig; John A Martignetti
Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.
Disease models & mechanisms 2013;6(2):397-403.
2013: Rémi Favier; Nathalie Hezard; Pierre Bedossa; Analisa Difeo; Monique Fabre; John A Martignetti
A new feature of the MYH9-related syndrome: chronic transaminase elevation.
Hepatology (Baltimore, Md.) 2013;57(3):1288-9.
2013: Olga Camacho-Vanegas; Irene Miranda-Lorenzo; Berrin Ozturk; Jacob Till; Sandra Catalina Camacho; John A Martignetti
Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013;27(2):432-6.
2012: Brad R Evans; Marc J Glucksman; Valerie Grum-Tokars; Mollie Lobl; Chiara R Martignetti; Catalina Camacho; Rebecca A Mosig; John A Martignetti
Mutation of membrane type-1 metalloproteinase, MT1-MMP, causes the multicentric osteolysis and arthritis disease Winchester syndrome.
American journal of human genetics 2012;91(3):572-6.
2012: Olga Camacho-Vanegas; Grace Cordovano; Marc J Glucksman; Benjamin Hoch; Virginia Kimonis; David F Bishop; Sandra Catalina Camacho; Sarju Mehta; Irene Miranda-Lorenzo; Keith D Philibert; Carsten A Raabe; Maria Celeste M Ramirez; Vern L Schramm; Esteban Terzo; Jacob Till; Giles Watts; John A Martignetti
Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.
American journal of human genetics 2012;90(4):614-27.
2012: Mario R Calderon; Analisa Difeo; John A Martignetti; Tali Shalom-Barak; Mark Verway; Beum-Soo An; David K Ann; Tarek A Bismar; John H White
Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.
The Journal of biological chemistry 2012;287(12):8662-74.
2012: Rebecca A Mosig; Ravi Sachidanandam; Peter Schlosshauer; Emir Senturk; Hardik Shah; Samantha Cohen; Maurizio D'Incalci; PR Dottino; Robert Fruscio; Fei Huang; Li Lin; Sergio Marchini; John A Martignetti
Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer.
Journal of ovarian research 2012;5():4.
2012: Rebecca A Mosig; Ravi Sachidanandam; Emir Senturk; Hardik Shah; Eugene Chudin; Samantha Cohen; Maurizio D'Incalci; PR Dottino; Robert Fruscio; Mollie Lobl; Sergio Marchini; John A Martignetti
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer.
Journal of ovarian research 2012;5(1):3.
2011: Keri B Sanborn; Alessandro Pecci; Gregory D Rak; James B Bussel; Analisa Difeo; Rémi Favier; Emily M Mace; John A Martignetti; Jordan S Orange
Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity.
Blood 2011;118(22):5862-71.
2011: Julie Deuquet; Ekkehart Lausch; Nicolas Guex; Laurence Abrami; Suzanne Salvi; Asvin Lakkaraju; Maria Celeste M Ramirez; John A Martignetti; Dariusz Rokicki; Luisa Bonafe; andrea superti-furga; F Gisou van der Goot
Hyaline fibromatosis syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors.
EMBO molecular medicine 2011;3(4):208-21.
2011: Brian D Radbill; Ritu Gupta; Maria Celeste M Ramirez; Analisa Difeo; John A Martignetti; Carlos E Alvarez; Scott L Friedman; Goutham Narla; Raluca Vrabie; Robert Bowles; Yedidya Saiman; Meena B Bansal
Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression.
Digestive diseases and sciences 2011;56(2):406-16.
2011: Deep Agnani; Catalina Camacho; Olga Camacho-Vanegas; Samantha Cohen; Peter Dottino; Shashi Lele; Kunle Odunsi; John A Martignetti
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression.
Journal of ovarian research 2011;4():18.
2010: Emir Senturk; Samantha Cohen; PR Dottino; John A Martignetti
A critical re-appraisal of BRCA1 methylation studies in ovarian cancer.
Gynecologic oncology 2010;119(2):376-83.
2010: Estefanía Rodríguez; Nana Aburjania; Nolan M Priedigkeit; Analisa Difeo; John A Martignetti
Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
PloS one 2010;5(9):.
2009: Analisa Difeo; Goutham Narla; John A Martignetti
Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.
The Mount Sinai journal of medicine, New York 2009;76(6):557-66.
2009: Estefanía Rodríguez; John A Martignetti
The Krüppel traffic report: cooperative signals direct KLF8 nuclear transport.
Cell research 2009;19(9):1041-3.
2009: Keri B Sanborn; Gregory D Rak; Saumya Y Maru; Korey Demers; Analisa Difeo; John A Martignetti; Michael R Betts; Rémi Favier; Pinaki Banerjee; Jordan S Orange
Myosin IIA associates with NK cell lytic granules to enable their interaction with F-actin and function at the immunological synapse.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(11):6969-84.
2009: Analisa Difeo; Fei Huang; Jaya Sangodkar; Esteban A Terzo; Devin Leake; Goutham Narla; John A Martignetti
KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.
Cancer research 2009;69(11):4733-41.
2009: Beyhan Tuysuz; Rebecca Mosig; Gürkan Altun; Selim Sancak; Marc J Glucksman; John A Martignetti
A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects.
European journal of human genetics : EJHG 2009;17(5):565-72.
2009: Julie Deuquet; Laurence Abrami; Analisa Difeo; Maria Celeste M Ramirez; John A Martignetti; F Gisou van der Goot
Systemic hyalinosis mutations in the CMG2 ectodomain leading to loss of function through retention in the endoplasmic reticulum.
Human mutation 2009;30(4):583-9.
2009: Jaya Sangodkar; Jiayan Shi; Analisa Difeo; Rachel Schwartz; Romina Bromberg; Aisha Choudhri; Kim McClinch; Raheleh Hatami; Elias Scheer; Sigal Kremer-Tal; John A Martignetti; Alex Hui; W K Leung; Scott L Friedman; Goutham Narla
Functional role of the KLF6 tumour suppressor gene in gastric cancer.
European journal of cancer (Oxford, England : 1990) 2009;45(4):666-76.
2009: Analisa Difeo; John A Martignetti; Goutham Narla
The role of KLF6 and its splice variants in cancer therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2009;12(1-2):1-7.
2008: Augusto Villanueva; Derek Chiang; Pippa Newell; Judit Peix; Swan Thung; Clara Alsinet; Victoria Tovar; Sasan Roayaie; Beatriz Minguez; Manel Sole; Carlo Battiston; Stijn Van Laarhoven; Maria I Fiel; Analisa Di Feo; Yujin Hoshida; Steven Yea; Sara Toffanin; Alex Ramos; John A Martignetti; Vincenzo Mazzaferro; Jordi Bruix; Samuel Waxman; Myron Schwartz; Matthew Meyerson; Scott L Friedman; Josep M Llovet
Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology 2008;135(6):1972-83, 1983.e1-11.
2008: Myron Schwartz; Igor Dvorchik; Sasan Roayaie; M Isabel Fiel; Sidney Finkelstein; J Wallis Marsh; John A Martignetti; Josep M Llovet
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers.
Journal of hepatology 2008;49(4):581-8.
2008: Mark Hartel; Goutham Narla; Moritz Wente; Nathalia A Giese; Marc E Martignoni; John A Martignetti; Helmut Friess; Scott L Friedman
Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
European journal of cancer (Oxford, England : 1990) 2008;44(13):1895-903.
2008: Goutham Narla; Analisa Difeo; Yolanda Fernandez; Saravana M Dhanasekaran; Fei Huang; Jaya Sangodkar; Eldad Hod; Devin Leake; Scott L Friedman; Simon J Hall; Arul M Chinnaiyan; William L Gerald; Mark A Rubin; John A Martignetti
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
The Journal of clinical investigation 2008;118(8):2711-21.
2008: Steven Yea; Goutham Narla; Xiao Zhao; Rakhi Garg; Sigal Tal-Kremer; Eldad Hod; Augusto Villanueva; Johnny Loke; Mirko Tarocchi; Kunihara Akita; Senji Shirasawa; Takehiko Sasazuki; John A Martignetti; Josep M Llovet; Scott L Friedman
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Gastroenterology 2008;134(5):1521-31.
2008: Analisa Difeo; Lauren Feld; Estefania Rodriguez; Christine Wang; David G Beer; John A Martignetti; Goutham Narla
A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
Cancer research 2008;68(4):965-70.
2008: Lisa E Lindvall; Tanya Kormeili; Elaine Chen; Maria Celeste M Ramirez; Valerie Grum-Tokars; Marc J Glucksman; John A Martignetti; Michael V Zaragoza; Senait W Dyson
Infantile systemic hyalinosis: Case report and review of the literature.
Journal of the American Academy of Dermatology 2008;58(2):303-7.
2007: Miriam S Teixeira; Olga Camacho-Vanegas; Yolanda Fernandez; Goutham Narla; Analisa Difeo; Bryant Lee; Tamara Kalir; Scott L Friedman; Nicolas F Schlecht; Eric M Genden; Mark L Urken; Margaret Brandwein-Gensler; John A Martignetti
KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
International journal of cancer. Journal international du cancer 2007;121(9):1976-83.
2007: Olga Camacho-Vanegas; Goutham Narla; Miriam S Teixeira; Analisa Difeo; Anjan Misra; Gobind Singh; Andrew M Chan; Scott L Friedman; Burt Feuerstein; John A Martignetti
Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
International journal of cancer. Journal international du cancer 2007;121(6):1390-5.
2007: Rebecca A Mosig; Oonagh Dowling; Analisa Difeo; Maria Celeste M Ramirez; Ian C Parker; Etsuko Abe; Janane Diouri; Aida Al Aqeel; James D Wylie; Samantha A Oblander; Joseph A Madri; Paolo Bianco; Suneel S Apte; Mone Zaidi; Stephen B Doty; Robert J Majeska; Mitchell B Schaffler; John A Martignetti
Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
Human molecular genetics 2007;16(9):1113-23.
2007: Shubha R Phadke; Maria Ramirez; Analisa Difeo; John A Martignetti; Katta M Girisha
Torg-Winchester syndrome: lack of efficacy of pamidronate therapy.
Clinical dysmorphology 2007;16(2):95-100.
2007: Sigal Kremer-Tal; Goutham Narla; Ying-bei Chen; Eldad Hod; Analisa Difeo; Steven Yea; Ju Seog Lee; Myron Schwartz; Swan N Thung; Isabel M Fiel; Michaela S Banck; Eran Zimran; Snorri S Thorgeirsson; Vincenzo Mazzaferro; Jordi Bruix; John A Martignetti; Josep M Llovet; Scott L Friedman
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
Journal of hepatology 2007;46(4):645-54.
2007: Richard J Antaya; Mariana M Cajaiba; Joseph A Madri; Maria A Lopez; Maria Celeste M Ramirez; John A Martignetti; Miguel Reyes-Múgica
Juvenile hyaline fibromatosis and infantile systemic hyalinosis overlap associated with a novel mutation in capillary morphogenesis protein-2 gene.
The American Journal of dermatopathology 2007;29(1):99-103.
2006: Joseph T C Shieh; Petra Swidler; John A Martignetti; Maria Celeste M Ramirez; Imelda Balboni; Julie Kaplan; Jeanette Kennedy; Omar A Abdul-Rahman; Gregory M Enns; Christy Sandborg; Anne Slavotinek; H Eugene Hoyme
Systemic hyalinosis: a distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2).
Pediatrics 2006;118(5):e1485-92.
2006: Boris Utsch; Analisa Difeo; Annegret Kujat; Stephanie M Karle; Volker Schuster; Harald Lenk; Ulla Jacobs; Martin Müller; Jörg Dötsch; Wolfgang Rascher; Heiko Reutter; John A Martignetti; Michael Ludwig; Ralf-Bodo Tröbs
Bladder exstrophy and Epstein type congenital macrothrombocytopenia: evidence for a common cause?
American journal of medical genetics. Part A 2006;140(20):2251-3.
2006: Analisa Difeo; Goutham Narla; Olga Camacho-Vanegas; H Nishio; Stephen L Rose; Richard E Buller; Scott L Friedman; Martin J Walsh; John A Martignetti
E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
Oncogene 2006;25(44):6026-31.
2006: Analisa Difeo; Goutham Narla; Jennifer Hirshfeld; Olga Camacho-Vanegas; Jyothsna Narla; Stephen L Rose; Tamara Kalir; Shen Yao; Alice Levine; Michael J Birrer; Tomas Bonome; Scott L Friedman; Richard E Buller; John A Martignetti
Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3730-9.
2006: Alexander Kirschenbaum; Xin-Hua Liu; Shen Yao; Goutham Narla; Scott L Friedman; John A Martignetti; Alice C Levine
Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones.
Carcinogenesis 2006;27(2):216-24.
2005: Jae-Ho Park; Efrat Eliyahu; Goutham Narla; Analisa Difeo; John A Martignetti; Edward H Schuchman
KLF6 is one transcription factor involved in regulating acid ceramidase gene expression.
Biochimica et biophysica acta 2005;1732(1-3):82-7.
2005: Dan Li; Steven Yea; Georgia Dolios; John A Martignetti; Goutham Narla; Rong Wang; Martin J Walsh; Scott L Friedman
Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation.
Cancer research 2005;65(20):9216-25.
2005: Goutham Narla; Analisa Difeo; Shen Yao; Asoka Banno; Eldad Hod; Helen L Reeves; Rui F Qiao; Olga Camacho-Vanegas; Alice Levine; Alexander Kirschenbaum; Andrew M Chan; Scott L Friedman; John A Martignetti
Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Cancer research 2005;65(13):5761-8.
2005: Marita S Teng; Margaret Brandwein-Gensler; Miriam S Teixeira; John A Martignetti; Dianne C Duffey
A study of TRAIL receptors in squamous cell carcinoma of the head and neck.
Archives of otolaryngology--head & neck surgery 2005;131(5):407-12.
2005: Goutham Narla; Analisa Difeo; Helen L Reeves; Daniel J Schaid; Jennifer Hirshfeld; Eldad Hod; Amanda Katz; William B Isaacs; Scott J Hebbring; Akira Komiya; Shannon K McDonnell; Kathy E Wiley; Steven J Jacobsen; Sarah D Isaacs; Patrick C Walsh; S Lilly Zheng; Bao-Li Chang; Danielle M Friedrichsen; Janet L Stanford; Elaine A Ostrander; Arul M Chinnaiyan; Mark A Rubin; Jianfeng Xu; Stephen N Thibodeau; Scott L Friedman; John A Martignetti
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Cancer research 2005;65(4):1213-22.
2004: Sigal Kremer-Tal; Helen L Reeves; Goutham Narla; Swan N Thung; Myron Schwartz; Analisa Difeo; Amanda Katz; Jordi Bruix; Paulette Bioulac-Sage; John A Martignetti; Scott L Friedman
Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 2004;40(5):1047-52.
2004: Alec C Kimmelman; Rui F Qiao; Goutham Narla; Asoka Banno; Nelson Lau; Paula D Bos; Nelson Nuñez Rodriguez; Bertrand C Liang; Abhijit Guha; John A Martignetti; Scott L Friedman; Andrew M Chan
Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.
Oncogene 2004;23(29):5077-83.
2004: Helen L Reeves; Goutham Narla; Olagunju Ogunbiyi; Asif I Haq; Amanda Katz; Sharon Benzeno; Eldad Hod; Noam Harpaz; Shlomit Goldberg; Sigal Tal-Kremer; Francis J Eng; Michael J P Arthur; John A Martignetti; Scott L Friedman
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.
Gastroenterology 2004;126(4):1090-103.
2003: Amos Toren; Galit Rozenfeld-Granot; Karen E Heath; Ninette Amariglio; Bianca Rocca; John Crosson; Charles J Epstein; Ferdinando Laghi; Raffaele Landolfi; Lena E Carlsson; Scott Argraves; Nicola Bizzaro; Marva Moxey-Mims; Frida Brok-Simoni; John A Martignetti; Andreas Greinacher; Gideon Rechavi
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation.
American journal of hematology 2003;74(4):254-62.
2003: Oonagh Dowling; Analisa Difeo; Maria Celeste M Ramirez; Turgut Tukel; Goutham Narla; Luisa Bonafe; Hulya Kayserili; Memnune Yuksel-Apak; Amy S Paller; Karen I Norton; Ahmad S Teebi; Valerie Grum-Tokars; Gail S Martin; George E Davis; Marc J Glucksman; John A Martignetti
Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.
American journal of human genetics 2003;73(4):957-66.
2003: Cheng Zhang; Youmei Xie; John A Martignetti; Tracy T Yeo; Stephen M Massa; Frank M Longo
A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs.
DNA and cell biology 2003;22(5):303-15.
2003: Goutham Narla; Scott L Friedman; John A Martignetti
Krüppel cripples prostate cancer: KLF6 progress and prospects.
The American journal of pathology 2003;162(4):1047-52.
2002: John A Martignetti
Five (un)easy pieces: the MYH9-related giant platelet syndromes.
Haematologica 2002;87(9):897-8.
2001: Goutham Narla; Karen E Heath; Helen L Reeves; Dan Li; Luciana E Giono; Alec C Kimmelman; Marc J Glucksman; J Narla; Francis J Eng; Andrew M Chan; Anna C Ferrari; John A Martignetti; Scott L Friedman
KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
Science (New York, N.Y.) 2001;294(5551):2563-6.
2001: Karen E Heath; Angel Campos-Barros; Amos Toren; Galit Rozenfeld-Granot; Lena E Carlsson; J Savige; JC Denison; Martin C Gregory; J G White; David Barker; Andreas Greinacher; Charles J Epstein; Marc J Glucksman; John A Martignetti
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
American journal of human genetics 2001;69(5):1033-45.
2001: John A Martignetti; A A Aqeel; W A Sewairi; C E Boumah; Marios Kambouris; S A Mayouf; K V Sheth; W A Eid; Oonagh Dowling; J Harris; Marc J Glucksman; S Bahabri; Brian F Meyer; Robert J Desnick
Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.
Nature genetics 2001;28(3):261-5.
2000: JW Tullai; Philip M Cummins; Amanda Pabon; James Roberts; M C Lopingco; Corie N Shrimpton; A Ian Smith; John A Martignetti; Emer S Ferro; Marc J Glucksman
The neuropeptide processing enzyme EC 3.4.24.15 is modulated by protein kinase A phosphorylation.
The Journal of biological chemistry 2000;275(47):36514-22.
2000: Marco Seri; Roberto Cusano; Simone Gangarossa; Gianluca Caridi; Domenico Bordo; Cristiana Lo Nigro; Gian Marco Ghiggeri; Roberto Ravazzolo; Maria Savino; M Del Vecchio; Maria D'Apolito; Achille Iolascon; Leopoldo Zelante; Anna Savoia; Carlo L Balduini; Patrizia Noris; Umberto Magrini; S Belletti; Karen E Heath; M Babcock; Marc J Glucksman; E Aliprandis; Nicola Bizzaro; Robert J Desnick; John A Martignetti
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.
Nature genetics 2000;26(1):103-5.
2000: AI al Aqeel; W Al Sewairi; B Edress; R J Gorlin; R J Desnick; John A Martignetti
Inherited multicentric osteolysis with arthritis: a variant resembling Torg syndrome in a Saudi family.
American journal of medical genetics 2000;93(1):11-8.
2000: John A Martignetti; Karen E Heath; J Harris; Nicola Bizzaro; Anna Savoia; Carlo L Balduini; Robert J Desnick
The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.
American journal of human genetics 2000;66(4):1449-54.
2000: Tao Yang; John A Martignetti; Stephen M Massa; Frank M Longo
Leukocyte common-antigen-related tyrosine phosphatase receptor: altered expression of mRNA and protein in the New England Deaconess Hospital rat line exhibiting spontaneous pheochromocytoma.
Carcinogenesis 2000;21(2):125-31.
2000: John A Martignetti; Bruce D Gelb; H Pierce; Piero Picci; Robert J Desnick
Malignant fibrous histiocytoma: inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22-evidence for a common genetic defect.
Genes, chromosomes & cancer 2000;27(2):191-5.
1999: Melissa P Wasserstein; John A Martignetti; R Zeitlin; Harry Lumerman; M Solomon; Marie E Grace; Robert J Desnick
Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.
American journal of medical genetics 1999;84(4):334-9.
1999: John A Martignetti; Robert J Desnick; E Aliprandis; Karen I Norton; P Hardcastle; S Nade; Bruce D Gelb
Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22.
American journal of human genetics 1999;64(3):801-7.
1999: E Aliprandis; J Harris; Barney Yoo; Bruce D Gelb; John A Martignetti
Isolation, characterization, and mapping of four novel polymorphic markers and an H3.3B pseudogene to chromosome 9p21-22.
Journal of human genetics 1999;44(5):348-9.
1998: V Basile; A Vicente; John A Martignetti; Boris Skryabin; Jürgen Brosius; James L Kennedy
Assignment of the human BC200 RNA gene (BCYRN1) to chromosome 2p16 by radiation hybrid mapping.
Cytogenetics and cell genetics 1998;82(3-4):271-2.
1996: Bruce D Gelb; K Moissoglu; J Zhang; John A Martignetti; D Brömme; Robert J Desnick
Cathepsin K: isolation and characterization of the murine cDNA and genomic sequence, the homologue of the human pycnodysostosis gene.
Biochemical and molecular medicine 1996;59(2):200-6.
1996: Karen I Norton; J M Wagreich; L Granowetter; John A Martignetti
Diaphyseal medullary stenosis (sclerosis) with bone malignancy (malignant fibrous histiocytoma): Hardcastle syndrome.
Pediatric radiology 1996;26(9):675-7.
1995: John A Martignetti; Jürgen Brosius
BC1 RNA: transcriptional analysis of a neural cell-specific RNA polymerase III transcript.
Molecular and cellular biology 1995;15(3):1642-50.
1994: J Kim; John A Martignetti; M R Shen; Jürgen Brosius; Prescott L Deininger
Rodent BC1 RNA gene as a master gene for ID element amplification.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(9):3607-11.
1993: John A Martignetti; Jürgen Brosius
BC200 RNA: a neural RNA polymerase III product encoded by a monomeric Alu element.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):11563-7.
1993: Frank M Longo; John A Martignetti; J M Le Beau; J S Zhang; J P Barnes; J Brosius
Leukocyte common antigen-related receptor-linked tyrosine phosphatase. Regulation of mRNA expression.
The Journal of biological chemistry 1993;268(35):26503-11.
1993: John A Martignetti; Jürgen Brosius
Neural BC1 RNA as an evolutionary marker: guinea pig remains a rodent.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(20):9698-702.
1992: James L Kennedy; William Honer; C A Kaufmann; John A Martignetti; Jürgen Brosius; K K Kidd
Two RFLPs near HOX2@/NGFR at locus D17S444E.
Nucleic acids research 1992;20(5):1171.
1991: John A Martignetti; B G Barrell
Sequence of the HindIII T fragment of human cytomegalovirus, which encodes a DNA helicase.
The Journal of general virology 1991;72 ( Pt 5)():1113-21.
1991: Alan T Bankier; S Beck; R Bohni; C M Brown; R Cerny; M S Chee; Clyde A Hutchison; T Kouzarides; John A Martignetti; E Preddie
The DNA sequence of the human cytomegalovirus genome.
DNA sequence : the journal of DNA sequencing and mapping 1991;2(1):1-12.
1990: M S Chee; Alan T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; Clyde A Hutchison; T Kouzarides; John A Martignetti
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Current topics in microbiology and immunology 1990;154():125-69.